share_log

四環醫藥：自願公告 - 參與聯合體中選吉藥控股破產重整項目預重整投資人

SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - PARTICIPATION IN THE CONSORTIUM WHO WAS SELECTED AS THE PRE-RESTRUCTURING INVESTOR FOR THE BANKRUPTCY AND RESTRUCTURING PROJECT OF JI YAO HOLDING

香港交易所 ·  Feb 7 06:49
Summary by Moomoo AI
四環醫藥控股集團有限公司（「四環醫藥」）宣布，其附屬公司隆裕弘達投資管理有限公司與其他投資者組成的聯合體，已被選為吉藥控股破產重整項目的預重整投資人。吉藥控股，一家主營醫藥及化工業務的深圳證券交易所創業板上市公司，於2023年11月27日被通化市中級人民法院決定啟動預重整程序。四環醫藥表示，聯合體的中選取決於重整投資協議的簽署及前提條件的達成，目前尚未訂立協議，且無法保證交易最終實現。公司提醒投資者及股東在交易股份時應審慎行事。該消息於2024年2月7日由四環醫藥主席兼執行董事車馮升醫生發布。
四環醫藥控股集團有限公司（「四環醫藥」）宣布，其附屬公司隆裕弘達投資管理有限公司與其他投資者組成的聯合體，已被選為吉藥控股破產重整項目的預重整投資人。吉藥控股，一家主營醫藥及化工業務的深圳證券交易所創業板上市公司，於2023年11月27日被通化市中級人民法院決定啟動預重整程序。四環醫藥表示，聯合體的中選取決於重整投資協議的簽署及前提條件的達成，目前尚未訂立協議，且無法保證交易最終實現。公司提醒投資者及股東在交易股份時應審慎行事。該消息於2024年2月7日由四環醫藥主席兼執行董事車馮升醫生發布。
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) announces that a joint venture consisting of its subsidiary Long Yue Hongda Investment Management Limited and other investors has been selected as a pre-restructuring investor in the bankruptcy restructuring project of Yizhiyuk Holdings. JIYU HOLDINGS, A SHENZHEN STOCK EXCHANGE START-LISTED COMPANY THAT OPERATES PHARMACEUTICAL AND CHEMICAL INDUSTRIES, WAS ORDERED TO INITIATE THE PRE-WEIGHTING PROCESS ON 27 NOVEMBER 2023 BY THE TUNGHUA CITY INTERMEDIATE PEOPLE'S COURT. Quadruple Pharmaceuticals said that selection in the consortium is subject to the achievement of the signing and prerequisites for the restructuring agreement. The agreement has not yet been concluded and the transaction cannot be guaranteed to be finalised. The Company reminds investors and shareholders to exercise caution when trading shares. The announcement was made on February 7, 2024 by Dr. Che Feng Sheng, Chairman and Executive Director of Four Wan Pharmaceuticals.
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) announces that a joint venture consisting of its subsidiary Long Yue Hongda Investment Management Limited and other investors has been selected as a pre-restructuring investor in the bankruptcy restructuring project of Yizhiyuk Holdings. JIYU HOLDINGS, A SHENZHEN STOCK EXCHANGE START-LISTED COMPANY THAT OPERATES PHARMACEUTICAL AND CHEMICAL INDUSTRIES, WAS ORDERED TO INITIATE THE PRE-WEIGHTING PROCESS ON 27 NOVEMBER 2023 BY THE TUNGHUA CITY INTERMEDIATE PEOPLE'S COURT. Quadruple Pharmaceuticals said that selection in the consortium is subject to the achievement of the signing and prerequisites for the restructuring agreement. The agreement has not yet been concluded and the transaction cannot be guaranteed to be finalised. The Company reminds investors and shareholders to exercise caution when trading shares. The announcement was made on February 7, 2024 by Dr. Che Feng Sheng, Chairman and Executive Director of Four Wan Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more